SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-138138
Filing Date
2024-12-18
Accepted
2024-12-18 20:56:09
Documents
1
Period of Report
2024-12-16

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5774
  Complete submission text file 0000950170-24-138138.txt   7229
Mailing Address C/O ONCOBIOLOGICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address
Gangloff Scott A. (Reporting) CIK: 0001663253 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 241560755

Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)